Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT01945879

Pilot Safety Trial of Chemotherapy and Use of Heparin in Patients With Pancreatic Cancer

Pilot Study of Intensified Chemotherapy and Simultaneous Treatment With Heparin in Out-patients With Pancreatic Cancer.

Sponsor: CONKO-Studiengruppe

Interventions Enoxaparine

Updated 5 times since 2017 Last updated: Sep 16, 2013 Started: Jan 31, 2003 Primary completion: Apr 30, 2004 Completion: Apr 30, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Pancreatic Cancer, this trial is completed. The trial is conducted by CONKO-Studiengruppe and has accumulated 5 data snapshots since 2003. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Jan 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CONKO-Studiengruppe

Data source: CONKO-Studiengruppe

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Berlin, Germany